EDTA-dependent pseudothrombocytopenia: Further insights and recommendations for prevention of a clinically threatening artifact

Clinical Chemistry and Laboratory Medicine

Volumn 50, Issue 8, 2012, Pages 1281-1285

  Lippi, Giuseppe ^a   Plebani, Mario ^b  

^a Academic Hospital of Parma   (Italy)

^b UNIVERSITY HOSPITAL OF PADOVA   (Italy)

Author keywords

EDTA; Hematology; Platelet; Pseudothrombocytopenia; Thrombocytopenia

Indexed keywords

ACETYLSALICYLIC ACID; AMIKACIN; AMINOGLYCOSIDE; ANTITHROMBOCYTIC AGENT; APYRASE; CALCIUM CHLORIDE; CARDIOLIPIN ANTIBODY; CD63 ANTIGEN; CITRATE SODIUM; CITRATE TRISODIUM; EDETIC ACID; ETOFYLLINE; FIBRINOGEN; FLUORIDE SODIUM; GLYCOPROTEIN IIB; GLYCOPROTEIN IIIA; HEPARIN; IMMUNOGLOBULIN G ANTIBODY; IMMUNOGLOBULIN M; IMMUNOGLOBULIN M ANTIBODY; KANAMYCIN; MONOCLONAL ANTIBODY; PADGEM PROTEIN; PROSTAGLANDIN E1; PROTEIN TYROSINE KINASE; PYRIDOXAL 5 PHOSPHATE; THROMBOCYTE ANTIBODY; TROMETAMOL; VON WILLEBRAND FACTOR;

ANTICOAGULATION; ANTIGEN EXPRESSION; ANTIPHOSPHOLIPID SYNDROME; ARTIFACT REDUCTION; BLOOD CELL; BLOOD SAMPLING; BLOOD SMEAR; CELL STRUCTURE; DECISION MAKING; DIAGNOSTIC ERROR; DISSEMINATED INTRAVASCULAR CLOTTING; ENZYME ACTIVATION; ETHYLENEDIAMINETETRA ACETIC ACID DEPENDENT PSEUDOTHROMBOCYTOPENIA; FLOW CYTOMETRY; HEPARIN INDUCED THROMBOCYTOPENIA; HISTOGRAM; HUMAN; IMMUNOFLUORESCENCE; IN VITRO STUDY; NEUTROPHIL; PREVALENCE; PRIORITY JOURNAL; REVIEW; ROOM TEMPERATURE; THROMBOCYTE AGGLUTINATION; THROMBOCYTE AGGREGATION; THROMBOCYTE COUNT; THROMBOCYTE DISORDER; THROMBOCYTOPENIA;

ANTICOAGULANTS; EDETIC ACID; HUMANS; THROMBOCYTOPENIA;

EID: 84867834182     PISSN: 14346621     EISSN: 14374331     Source Type: Journal    
DOI: 10.1515/cclm-2012-0081     Document Type: Review

References (35)

1. Banfi G, Salvagno GL, Lippi G. The role of ethylenediamine tetraacetic acid (EDTA) as in vitro anticoagulant for diagnostic purposes. Clin Chem Lab Med 2007;45:565-76.
2. Lippi U, Schinella M, Modena N, Nicoli M. Unpredictable effects of K3 EDTA on mean platelet volume. Am J Clin Pathol 1987;87:391-3.
3. Shreiner DP, Bell WR. Pseudothrombocytopenia: manifestation of a new type of platelet agglutinin. Blood 1973;42:541-9.
4. Casonato A, Bertomoro A, Pontara E, Dannhauser D, Lazzaro AR, Girolami A. EDTA dependent pseudothrombocytopenia caused by antibodies against the cytoadhesive receptor of platelet gpIIB-IIIA. J Clin Pathol 1994;47:625-30.
5. Schrezenmeier H, Müller H, Gunsilius E, Heimpel H, Seifried E. Anticoagulant-induced pseudothrombocytopenia and pseudoleucocytosis. Thromb Haemost 1995;73:506-13.
6. Golański J, Pietrucha T, Baj Z, Greger J, Watala C. Molecular insights into the anticoagulant-induced spontaneous activation of platelets in whole blood-various anticoagulants are not equal. Thromb Res 1996;83:199-216.
7. Bizzaro N, Brandalise M. EDTA-dependent pseudothrombocytopenia. Association with antiplatelet and antiphospholipid antibodies. Am J Clin Pathol 1995;103:103-7.
8. Golański J, Pietrucha T, Baj Z, Greger J, Watala C. A novel approach to inhibit the anticoagulant-induced spontaneous activation of blood platelets-effect of magnesium on platelet release reaction in whole blood. Thromb Res 1997;85:127-32.
9. Bartels PC, Schoorl M, Lombarts AJ. Screening for EDTA-dependent deviations in platelet counts and abnormalities in platelet distribution histograms in pseudothrombocytopenia. Scand J Clin Lab Invest 1997;57:629-36.
10. Allerheiligen D, Houston R, Vermedahl B. EDTA-induced pseudothrombocytopenia. J Am Board Fam Pract 1996;9:212-4.
11. Bizzaro N. EDTA-dependent pseudothrombocytopenia: a clinical and epidemiological study of 112 cases, with 10-year follow-up. Am J Hematol 1995;50:103-9.
12. Ohno N, Kobayashi M, Hayakawa S, Utsunomiya A, Karakawa S. Transient pseudothrombocytopenia in a neonate: transmission of a maternal EDTA-dependent anticoagulant. Platelets [Epub 2011 Oct. 11].
13. Wills TB, Wardrop KJ. Pseudothrombocytopenia secondary to the effects of EDTA in a dog. J Am Anim Hosp Assoc 2008;44:95-7.
14. Silvestri F, Virgolini L, Savignano C, Zaja F, Velisig M, Baccarani M. Incidence and diagnosis of EDTA-dependent pseudothrombocytopenia in a consecutive outpatient population referred for isolated thrombocytopenia. Vox Sang 1995;68:35-9.
15. Pegels JG, Bruynes EC, Engelfriet CP, Von Dem Borne AE. Pseudothrombocytopenia: an immunologic study on platelet antibodies dependent on ethylene diamine tetra-acetate. Blood 1982;59:157-61.
16. Mehdi AA, Salti I, Uthman I. Antiphospholipid syndrome: endocrinologic manifestations and organ involvement. Semin Thromb Hemost 2011;37:49-57.
17. Favaloro EJ, Wong RC. Laboratory testing for the antiphospholipid syndrome: making sense of antiphospholipid antibody assays. Clin Chem Lab Med 2011;49:447-61.
18. Galifi M, Schinella M, Nicoli M, Lippi G. Instrumental reports and effect of anticoagulants in a case of neutrophil agglutination in vitro. Haematologica 1993;78:364-70.
19. Lassila R, Antovic JP, Armstrong E, Baghaei F, Dalsgaard-Nielsen J, Hillarp A, et al. Practical viewpoints on the diagnosis and management of heparin-induced thrombocytopenia. Semin Thromb Hemost 2011;37:328-36.
20. Favaloro EJ. Laboratory testing in disseminated intravascular coagulation. Semin Thromb Hemost 2010;36:458-67.
21. Wu W, Guo Y, Zhang L, Cui W, Li W, Zhang S. Clinical utility of automated platelet clump count in the screening for ethylene diamine tetraacetic acid-dependent pseudothrombocytopenia. Chin Med J (Engl) 2011;124:3353-7.
22. Ohnuma O, Shirata Y, Miyazawa K. Use of theophylline in the investigation of pseudothrombocytopenia induced by edetic acid (EDTA-2K). J Clin Pathol 1988;41:915-7.
23. Lippi G, Guidi G, Nicoli M. Platelet count in EDTA-dependent pseudothrombocytopenia. Eur J Haematol 1996;56:112-3.
24. Lippi U, Schinella M, Nicoli M, Modena N, Lippi G. EDTA-induced platelet aggregation can be avoided by a new anticoagulant also suitable for automated complete blood count. Haematologica 1990;75:38-41.
25. Lippi U, Schinella M, Modena N, Nicoli M, Lippi G. Advantages of a new anticoagulant in routine hematology on the Coulter Counter S-Plus STKR analyzer. Am J Clin Pathol 1990;93:760-4.
26. Ozcelik F, Arslan E, Serdar MA, Yiginer O, Oztosun M, Kayadibi H, et al. A useful method for the detection of ethylenediaminetetraacetic acid-and cold agglutinin-dependent pseudothrombocytopenia. Am J Med Sci Epub 2012 Jan 6.
27. Zhou X, Wu X, Deng W, Li J, Luo W. Amikacin can be added to blood to reduce the fall in platelet count. Am J Clin Pathol 2011;136:646-52.
28. Sakurai S, Shiojima I, Tanigawa T, Nakahara K. Aminoglycosides prevent and dissociate the aggregation of platelets in patients with EDTA-dependent pseudothrombocytopenia. Br J Haematol 1997;99:817-23.
29. Ahn HL, Jo YI, Choi YS, Lee JY, Lee HW, Kim SR, et al. EDTA-dependent pseudothrombocytopenia confirmed by supplementation of kanamycin; a case report. Korean J Intern Med 2002;17:65-8.
30. Chae H, Kim M, Lim J, Oh E-J, Kim Y, Han K. Novel method to dissociate platelet clumps in EDTA-dependent pseudothrombocytopenia based on the pathophysiological mechanism. Clin Chem Lab Med 2012;50:1393-7.
31. Lippi G, Plebani M, Simundic AM. Quality in laboratory diagnostics: from theory to practice. Biochem Med (Zagreb) 2010;20:126-30.
32. Plebani M, Lippi G. Closing the brain-to-brain loop in laboratory testing. Clin Chem Lab Med 2011;49:1131-3.
33. Lippi G, Chance JJ, Church S, Dazzi P, Fontana R, Giavarina D, et al. Preanalytical quality improvement: from dream to reality. Clin Chem Lab Med 2011;49:1113-26.
34. Sciacovelli L, O'Kane M, Skaik YA, Caciagli P, Pellegrini C, Da Rin G, et al. IFCC WG-LEPS. Quality indicators in laboratory medicine: from theory to practice. Preliminary data from the IFCC Working Group Project " Laboratory Errors and Patient Safety ". Clin Chem Lab Med 2011;49:835-44.
35. Lippi G, Facchinetti R. Accurate platelet count avoiding platelet clumping. Lab Hematol 1998;4:225-6.